Fbxo22 inhibits metastasis in triple-negative breast cancer through ubiquitin modification of KDM5A and regulation of H3K4me3 demethylation

Siqiaozhi Li, Jinsong He, Xin Liao, Yixuan He, Rui Chen, Junhui Chen, Sean Hu, Jia Sun

Open source

DOI
10.1007/s10565-022-09754-w
Published
2022-09-16
Container
Cell Biology and Toxicology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10565-022-09754-w,
  title = {Fbxo22 inhibits metastasis in triple-negative breast cancer through ubiquitin modification of KDM5A and regulation of H3K4me3 demethylation},
  author = {Siqiaozhi Li and Jinsong He and Xin Liao and Yixuan He and Rui Chen and Junhui Chen and Sean Hu and Jia Sun},
  year = {2022},
  journal = {Cell Biology and Toxicology},
  doi = {10.1007/s10565-022-09754-w},
  url = {https://doi.org/10.1007/s10565-022-09754-w}
}

RIS

TY  - JOUR
TI  - Fbxo22 inhibits metastasis in triple-negative breast cancer through ubiquitin modification of KDM5A and regulation of H3K4me3 demethylation
AU  - Siqiaozhi Li
AU  - Jinsong He
AU  - Xin Liao
AU  - Yixuan He
AU  - Rui Chen
AU  - Junhui Chen
AU  - Sean Hu
AU  - Jia Sun
PY  - 2022
JO  - Cell Biology and Toxicology
DO  - 10.1007/s10565-022-09754-w
UR  - https://doi.org/10.1007/s10565-022-09754-w
ER  - 

APA

Li, S., He, J., Liao, X., He, Y., Chen, R., Chen, J., Hu, S., & Sun, J. (2022). Fbxo22 inhibits metastasis in triple-negative breast cancer through ubiquitin modification of KDM5A and regulation of H3K4me3 demethylation. Cell Biology and Toxicology. https://doi.org/10.1007/s10565-022-09754-w

Source records